European Journal of Pediatrics

, Volume 153, Issue 4, pp 271–275 | Cite as

Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia

  • S. P. Dibenedetto
  • R. Ragusa
  • A. Sciacca
  • A. Di Cataldo
  • V. Miraglia
  • S. D'Amico
  • L. Lo Nigro
  • A. M. Ippolito
Hematology/Oncology Original Paper

Abstract

A group of 90 patients with acute lymphoblastic leukaemia (ALL) in first continuous complete remission (CCR), admitted in our hospital between January 1986 and September 1992, were tested for the presence of antibodies against hepatitis C virus (HCV), antibodies against hepatitis B virus and antibodies against HIV-1 during maintenance therapy or thereafter. They were compared with a group of 71 children with other malignancies in first CCR who had been diagnosed consecutively from January 1986 to September 1992. No patient with ALL or any other malignancy was found to be positive for hepatitis B surface antigen or HIV-1. HCV-specific antibodies were detected in 28 out of 87 children (32.1%) with ALL and in 4 out of 44 patients (9%) with malignancies other than ALL who had received at least one transfusion of blood or platelets (P<0.01). HCV-specific antibodies were also detected in one out of three untransfused children with ALL but in none of the untransfused children with malignancies other than ALL. HCV-specific seropositivity influenced the management of children with ALL during maintenance therapy. In fact, as a result of abnormal liver function tests, maintenance therapy had to be suspended significantly more often in the case of HCV-seropositive patients with ALL than in HCV-seronegative ones. Despite the high morbidity during maintenance therapy, chronic liver disease (CLD) was uncommon in both groups: five children with ALL (17.2% of HCV-seropositive children) and one child with a malignancy other than ALL (25%) had CLD. If a follow up for a longer period confirms these observations the impact of HCV-related CLD on the quality of life and survival of patients with ALL or other malignancies will probably be minimal.

Key words

Acute lymphoblastic leukaemia Hepatitis C virus 

Abbreviations

ALL

acute lymphoblastic leukaemia

CCR

continuous complete remission

CLD

chronic liver disease (biochemically evident)

HBV

hepatitis B virus

HCV

hepatitis C virus

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ (1991) Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 325: 1325–1329PubMedGoogle Scholar
  2. 2.
    Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A (1992) Hepatitis C viremia and liver disease in symtpom-free individuals with anti-HCV. Lancet 340: 697–698CrossRefPubMedGoogle Scholar
  3. 3.
    Alter HJ, Purceli RH, Shih JW, Melpolder JC, Houghton M, Choo Q, Kuo G (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med 321: 1494–1500PubMedGoogle Scholar
  4. 4.
    Alter MJ, Margolis HS, Krawczynsky K, Judson FN, Mares A, Alexander WG, Hu PY, Miller JK (1992) The natural history of community acquired hepatitis C in the United States. N Engl J Med 327: 1899–1905PubMedGoogle Scholar
  5. 5.
    Bassetti D, Cutrupi V, Dallago B, Alfonsi P, Leon A, Canton R, Elia M, Mateos M, Ebeling F, Naukkarinen, Myllyla, Leikola J (1991) Second-generation RIBA to confirm diagnosis of HCV infection. Lancet 337: 912–913CrossRefPubMedGoogle Scholar
  6. 6.
    Brettler BD, Mannucci PM, Gringeri A, Rasko JE, Forsberg AD, Rumi MG, Garsia RJ, Rickard KA, Colombo M (1992) The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 80: 540–543PubMedGoogle Scholar
  7. 7.
    Brink NS, Chopra R, Perrons CJ, Ring CJA, Garson GA, Briggs EM, Goldstone AH, Linch DC, Tedder RS (1993) Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virologic study. Br J Haematol 83: 498–503PubMedGoogle Scholar
  8. 8.
    Czaja AJ (1992) Chronic hepatitis C virus infection. A disease in waiting? N Engl J Med 327: 1949–1950PubMedGoogle Scholar
  9. 9.
    Donahue JG, Munoz DVMA, Ness PM, Brown DE Jr, Jawn DH, McAllister HA Jr (1992) The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327: 369–373PubMedGoogle Scholar
  10. 10.
    Esteban JI, Estaban R, Viladomiu L, Lopez-Alavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J, Houghton M, Choo QL, Kuo G (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet II: 987CrossRefGoogle Scholar
  11. 11.
    Farci P, Alter HJ, Wongog D, Miller RH, Shih JW, Jett B, Purcell RH (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325: 98–104PubMedGoogle Scholar
  12. 12.
    Hetherington ML, Buchanan GR (1988) Elevated serum transaminase Values During therapy for acute lymphoblastic leukemia correlate with prior blood transfusion. Cancer 62: 1614–1618PubMedGoogle Scholar
  13. 13.
    Kolho E, Ruutu P, Ruutu T (1993) Hepatitis C infection in BMT patients. Bone Marrow Transplant 11: 119–123Google Scholar
  14. 14.
    Larsen J, Skaug K, Maeland A (1992) Second-generation anti-HCV test predicts infectivity. Vox Sang 63: 39–42PubMedGoogle Scholar
  15. 15.
    Laureys G, Verelst H, Dhooge C, Leroux-Roels G, Van Renterghem L, Benoit Y, (1992) Hepatitis C in children with ALL. Abstracts. Proceedings of the S. I. O. P. XXIV Meeting. P 225: 447Google Scholar
  16. 16.
    Locasciulli A, Alberti A, Barbieri R, Realdi G, Uderzo C, Portmann B, Masera G (1983) Evidence of non-A non-B hepatitis in children with acute leukemia and chronic liver disease. Am J Dis Child 137: 354–356PubMedGoogle Scholar
  17. 17.
    Locasciulli A, Gornati G, Tagger A, Ribero ML, Cavalletto D, Cavalletto L, Masera G, Shulman HM, Portmann B, Alberti A (1991) Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 78: 1619–1622PubMedGoogle Scholar
  18. 18.
    Malone W, Novak R (1980) Outcome of hepatitis in children with acute leukemia. Am J Dis Child 134: 584–587PubMedGoogle Scholar
  19. 19.
    Murphy MF, Waters AH, Grint PCA, Hardiman AE, Lister TA (1990) Hepatitis C infection in multitransfused patients with acute leukemia. Lancet 335: 58–59CrossRefGoogle Scholar
  20. 20.
    Nelson KE, Donahue JG, Stambolis V, Kleinman S, Busch M, Holland P (1992) Post-transfusion hepatitis C virus infection. N Engl J Med 327: 1601–1602PubMedGoogle Scholar
  21. 21.
    Paolucci G, Masera G, Vecchi V, Marsoni S, Pession A, Zurlo MG (1989) Treating childhood acute lymphoblastic leukemia (ALL): summary of ten year's experience in Italy. Med Pediatr Oncol 17: 83–91PubMedGoogle Scholar
  22. 22.
    Pereira BJG, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ (1992) Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 327: 910–915PubMedGoogle Scholar
  23. 23.
    Polish LB, Shapiro CN, Bauer F, Klotz P, Ginier P, Roberto RR, Margolis HS, Alter MJ (1992) Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 326: 721–725PubMedGoogle Scholar
  24. 24.
    Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A (1992) Hepatitis C virus antibodies in a long-term follow-up of β-thalassemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr 573–576Google Scholar
  25. 25.
    Riehm H, Langerman HJ, Gadner H, Odenwald E, Henze G (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol 4: 299–306Google Scholar
  26. 26.
    Rossetti F, Cesaro S, Pizzocchero P, Cadrobbi P, Guido M, Zanesco L (1992) Chronic hepatitis B surface antigen-negative hepatitis after treatment of malignancy. J Pediatr 121: 39–43PubMedGoogle Scholar
  27. 27.
    Seeff LB, Buskell-Bales Z, Wringht EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick GM, Knodell RG, Perillo RP, Stevens CE, Hollongsworth CG, and the National Heart, Lung, and Blood Institute Study Group (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327: 1906–1911PubMedGoogle Scholar
  28. 28.
    Sirchia G, Almini D, Bellobuono A, Giovannetti AM, Marconi M, Mercuriali F, Mozzi F, Parravicini A, Pizzi M, Zanuso F, and the Italian Cooperative Group (1990) Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sanguinis 59: 26–29PubMedGoogle Scholar
  29. 29.
    Van Der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, Lelie PN (1990) Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 335: 558–560CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • S. P. Dibenedetto
    • 1
  • R. Ragusa
    • 1
  • A. Sciacca
    • 1
  • A. Di Cataldo
    • 1
  • V. Miraglia
    • 1
  • S. D'Amico
    • 1
  • L. Lo Nigro
    • 1
  • A. M. Ippolito
    • 1
  1. 1.Division of Paediatric Haematology-OncologyUniversity of CataniaCataniaItaly

Personalised recommendations